Cargando…
Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy
Breast carcinoma is a major health issue for millions of women. Current therapies have serious side effects, and are only partially effective in patients with metastatic tumors. Thus, the need for novel and less toxic therapies is urgent. Moreover, hormonal and antibody therapies effective in other...
Autores principales: | Mirandola, Leonardo, Pedretti, Elisa, Figueroa, Jose A., Chiaramonte, Raffaella, Colombo, Michela, Chapman, Caroline, Grizzi, Fabio, Patrinicola, Federica, Kast, W. Martin, Nguyen, Diane D., Rahman, Rakhshanda Layeequr, Daver, Naval, Ruvolo, Peter, Post, Sean M., Bresalier, Robert S., Chiriva-Internati, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650349/ https://www.ncbi.nlm.nih.gov/pubmed/29088794 http://dx.doi.org/10.18632/oncotarget.20102 |
Ejemplares similares
-
Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets
por: Mirandola, Leonardo, et al.
Publicado: (2014) -
Cancer Testis Antigen Vaccination Affords Long-Term Protection in a Murine Model of Ovarian Cancer
por: Chiriva-Internati, Maurizio, et al.
Publicado: (2010) -
A novel method for efficient generation of antigen-specific effector T-cells using dendritic cells transduced with recombinant adeno-associated virus and p38 kinase blockade
por: Mirandola, Leonardo, et al.
Publicado: (2019) -
The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma
por: Schutt, Christopher A., et al.
Publicado: (2017) -
Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
por: Colombo, Michela, et al.
Publicado: (2018)